Wei Qi

This inventor holds 17 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 9 EPO patents. Top assignees: Novartis Ag, Cisco Technology, Inc., Shanghai United Imaging Healthcare Co., Ltd.. Active years: 2016-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wei Qi. Retrieved from https://idiyas.com/inventor/wei-qi-7vgcbhab

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 (Patent Applications = 4)

% Patents Active = 88.2

CIPO Patents = 1

EPO Patents = 9 (Patent Applications = 12)

Average Co-Inventor Count = 3.8

ph-index = 3

Forward Citations = 50(Granted Patents)

Company Filing History:

Cisco Technology, Inc.

patents

3 out of 887

Shanghai United Imaging Healthcare Co., Ltd.

patents

4. 2 out of 6

Shanghai Unicar-Therapy Bio-Medicine Technology Co., Ltd

patents

5. 1 out of 1

Jing Medicine Technology (Shanghai) Ltd.

patent

6. 1 out of 87

Shanghaitech University

patents

where one patent can have more than one assignee

Years Active: 2016-2026

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12552796 - EED inhibitor, and preparation method therefor and use thereof (2026-02-17),

2. 12208282 - Cavity of medical device and medical system including the medical device (2025-01-28),

3. 11931363 - Triazolopyrimidine compounds and uses thereof (2024-03-19),

4. 11778771 - Airflow control louver for bidirectional airflow cooling (2023-10-03),

5. 11690580 - Supporting device in medical diagnostics system (2023-07-04),

6. 11207325 - Triazolopyrimidine compounds and uses thereof (2021-12-28),

7. 11098123 - OCTS technology-based pancreatic cancer and malignant mesothelioma CAR-T therapeutic vector, construction method therefor, and use thereof (2021-08-24),

8. 11031723 - Cable header (2021-06-08),

9. 10987070 - Supporting device in medical diagnostics system (2021-04-27),

10. 10934357 - Malignant glioma CAR-T therapeutic vector based on OCTS technology, and construction method and application thereof (2021-03-02),

11. 10689378 - Triazolopyridine compounds and uses thereof (2020-06-23),

12. 10676479 - Imidazolepyridine compounds and uses thereof (2020-06-09),

13. 10283899 - Cable header (2019-05-07),

14. 10220036 - Triazolopyrimidine compounds and uses thereof (2019-03-05),

15. 9723745 - Line card ejector with line card removal indication (2017-08-01),

Title: Inventor Wei Qi: Pioneering Innovations in Medical Devices and Pharmaceuticals

Introduction

Wei Qi, an accomplished inventor based in Shanghai, China, has made significant contributions to the fields of medical devices and pharmaceuticals. With a remarkable portfolio of 16 patents, Qi has focused on solving complex challenges through innovative designs and compounds.

Latest Patents

Among Wei Qi's latest works are two notable patents. The first, titled "Cavity of medical device and medical system including the medical device," describes a sophisticated cavity structure within a medical device. This design enhances functionality by incorporating an accommodating cavity that aligns with the bore, allowing for better movement and positioning of the couch within the device. This innovation promises to improve patient care and treatment efficacy.

The second patent, "Triazolopyrimidine compounds and uses thereof," presents a new compound that shows potential in treating diseases associated with PRC2 pathways. The discovery of this compound could pave the way for new therapeutic options in treating complex medical conditions, demonstrating Qi's commitment to advancing healthcare.

Career Highlights

Wei Qi has gained valuable experience by working with renowned companies such as Novartis AG and Cisco Technology, Inc. These positions allowed him to collaborate with top-tier professionals and contribute to cutting-edge projects that push the boundaries of technology and medicine.

Collaborations

Throughout his career, Wei Qi has worked alongside talented individuals, including Ho Man Chan and Xiang-Ju Justin Gu. These collaborations have not only enriched his research but also fostered an environment of innovation and shared knowledge.

Conclusion

As an inventor, Wei Qi exemplifies the spirit of innovation in the medical and pharmaceutical industries. His 16 patents reflect his dedication to creating impactful solutions that address critical health challenges. With his continued research and collaboration, Wei Qi is set to remain a key figure in advancing technologies that enhance patient care and treatment outcomes.

Profile summary based on public USPTO records.